BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25879328)

  • 1. HPV positive oropharyngeal cancer and treatment deintensification: how pertinent is it?
    Laskar SG; Swain M
    J Cancer Res Ther; 2015; 11(1):6-9. PubMed ID: 25879328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and treatment strategy for HPV-related oropharyngeal cancer.
    Okami K
    Int J Clin Oncol; 2016 Oct; 21(5):827-835. PubMed ID: 27380170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of the oropharynx.
    Clump DA; Bauman JE; Ferris RL
    Surg Oncol Clin N Am; 2015 Jul; 24(3):509-20. PubMed ID: 25979397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.
    Gooi Z; Chan JY; Fakhry C
    Laryngoscope; 2016 Apr; 126(4):894-900. PubMed ID: 26845348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient.
    Gillison ML; Restighini C
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):1045-60. PubMed ID: 26568547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual health in oral oncology: breaking the news to patients with human papillomavirus-positive oropharyngeal cancer.
    Evans M; Powell NG
    Head Neck; 2014 Nov; 36(11):1529-33. PubMed ID: 24913820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
    Fung N; Faraji F; Kang H; Fakhry C
    Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human papilloma virus in head and neck cancer].
    Barry B; Ortholan C
    Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
    Maxwell JH; Grandis JR; Ferris RL
    Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus in oropharyngeal cancer: The changing face of a disease.
    Mallen-St Clair J; Alani M; Wang MB; Srivatsan ES
    Biochim Biophys Acta; 2016 Dec; 1866(2):141-150. PubMed ID: 27487173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
    Ang KK; Sturgis EM
    Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of human papillomavirus in oral cavity carcinomas.
    Machado J; Reis PP; Zhang T; Simpson C; Xu W; Perez-Ordonez B; Goldstein DP; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
    Head Neck Oncol; 2010 Mar; 2():6. PubMed ID: 20226055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
    Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
    Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
    Lam JO; Lim WY; Chow KY; D'Souza G
    PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing aetiology of head and neck cancer: the role of human papillomavirus.
    Evans M; Powell NG
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):538-46. PubMed ID: 20584591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
    O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
    J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.